Skip to main content
. 2007 Jun 6;64(6):758–771. doi: 10.1111/j.1365-2125.2007.02934.x

Table 2.

Adverse events leading to withdrawal from treatment in the sirolimus group

Patient Adverse events Intensity Day of onset Relationship to treatment
1 Wound dehiscence Severe  53 Possibly related to sirolimus
2 Leukopenia Moderate  51 Probably related to MMF
3 Human polyomavirus infection Moderate 121 Possibly related to sirolimus and remotely related to MMF
4 Diarrhoea Moderate  35 Probably related to MMF
5 Interstitial nephritis Severe  28 Probably related to sirolimus
5 Renal tubular necrosis Severe  31 Probably related to sirolimus